We are live on ! Find out more
GAA

Green Alpha Advisors Portfolio holdings

AUM $148M Turnover 14.17%
1-Year Est. Return 98.22%
This Fund
S&P 500
This Quarter Est. Return
+8.27%
1 Year Est. Return
+98.22%
3 Year Est. Return
+315.88%
5 Year Est. Return
+340.2%
10 Year Est. Return
–
AUM
$109M
AUM Growth
+$5.55M
Cap. Flow
+$5.21M
Cap. Flow %
4.78%
Top 10 Hldgs %
33.78%
Holding
121
New
19
Increased
65
Reduced
31
Closed
6
Avg Time Held
3.1 years
Top 10 Avg Time Held
1.4 years
Top 20 Avg Time Held
1.5 years

Top Sells

Rank Stock Value
1
SCS icon
Steelcase
SCS
+$2.65M
2
AAPL icon
Apple
AAPL
+$515K
3
SNPS icon
Synopsys
SNPS
+$464K
4
SWKS icon
Skyworks Solutions
SWKS
+$346K
5
RXRX icon
Recursion Pharmaceuticals
RXRX
+$303K

Sector Composition

Rank Sector Weight
1 Technology 53.11%
2 Healthcare 14.38%
3 Industrials 9.52%
4 Consumer Discretionary 6.48%
5 Utilities 6.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
SOPH icon
101
SOPHiA GENETICS
SOPH
$573M
$213K 0.2%
45,660
+4,444
+11% +$20.1K
2024 Q3
5 quarters
ARCT icon
102
Arcturus Therapeutics
ARCT
$294M
$173K 0.16%
28,282
+6,839
+32% +$73.9K
2025 Q1
3 quarters
TXG icon
103
10x Genomics
TXG
$9.1B
$166K 0.15%
10,153
-11,115
-52% -$168K
2024 Q4
4 quarters
RELY icon
104
Remitly
RELY
$5.11B
$163K 0.15%
+11,798
New +$171K
2025 Q4
0 quarters
MBLY icon
105
Mobileye
MBLY
$6.14B
$161K 0.15%
15,428
-17,178
-53% -$215K
2023 Q3
9 quarters
SHLS icon
106
Shoals Technologies Group
SHLS
$1.21B
$153K 0.14%
17,946
+1,091
+6% +$9.8K
2022 Q2
14 quarters
RPD icon
107
Rapid7
RPD
$850M
$152K 0.14%
10,026
-1,063
-10% -$17.5K
2021 Q3
17 quarters
NTLA icon
108
Intellia Therapeutics
NTLA
$1.6B
$150K 0.14%
+16,693
New +$230K
2025 Q4
0 quarters
INO icon
109
Inovio Pharmaceuticals
INO
$102M
$125K 0.11%
72,095
+24,007
+50% +$52.9K
2021 Q2
18 quarters
DNA icon
110
Ginkgo Bioworks
DNA
$692M
$119K 0.11%
14,327
+1,378
+11% +$14.8K
2023 Q1
11 quarters
ECX icon
111
ECARX Holdings
ECX
$334M
$102K 0.09%
59,310
-5,133
-8% -$10.4K
2024 Q4
4 quarters
ABCL icon
112
AbCellera Biologics
ABCL
$3.82B
$94.4K 0.09%
27,592
+4,817
+21% +$21.5K
2021 Q3
17 quarters
ACOG icon
113
Alpha Cognition
ACOG
$178M
$72.3K 0.07%
+11,126
New +$70.3K
2025 Q4
0 quarters
BEEM icon
114
Beam Global
BEEM
$20.2M
$71.1K 0.07%
47,374
+27,903
+143% +$64.1K
2022 Q1
15 quarters
QSI icon
115
Quantum-Si Incorporated
QSI
$245M
$56.7K 0.05%
51,528
-164,504
-76% -$268K
2023 Q3
9 quarters
AAPL icon
116
Apple
AAPL
$5.01T
– –
-2,021
Closed -$515K –
CVAC icon
117
DELISTED
CureVac
CVAC
– –
-12,928
Closed -$69.7K –
SCS icon
118
DELISTED
Steelcase
SCS
– –
-153,908
Closed -$2.65M –
SWKS icon
119
Skyworks Solutions
SWKS
$18.7B
– –
-4,500
Closed -$346K –
TPIC icon
120
DELISTED
TPI Composites
TPIC
– –
-164,109
Closed -$5.09K –
MGX icon
121
Metagenomi Therapeutics
MGX
$29.6M
– –
-14,252
Closed -$33.8K –

Similar funds

Green Alpha Advisors's Q4 2025 Portfolio in Review

As of Q4 2025, Green Alpha Advisors held 121 positions worth $109M, up 5.4% from $104M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Green Alpha Advisors deployed $5.21M of net new capital in Q4 2025, opening 19 new positions and adding to 65 existing holdings. Its largest new stake was Datadog: 5,162 shares worth $702K.

By sector, the portfolio is most concentrated in Technology at 53% of assets, up from 52% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was Synopsys, an estimated $464K trimmed.

  • Green Alpha Advisors's largest Q4 2025 buy was Datadog: 5,162 shares worth $702K.
  • Green Alpha Advisors added most to Symbotic in Q4 2025, an estimated $477K increase.
  • Green Alpha Advisors's biggest Q4 2025 reduction was Synopsys, cutting an estimated $464K.
  • Green Alpha Advisors fully exited Steelcase in Q4 2025, selling an estimated $2.65M.
  • Green Alpha Advisors's ten largest holdings make up 34% of its $109M portfolio in Q4 2025.
  • Green Alpha Advisors opened 19 new positions and closed 6 in Q4 2025.
  • Green Alpha Advisors's portfolio value rose 5.4% quarter-over-quarter to $109M.

Based on Green Alpha Advisors's 13F filing for Q4 2025, filed 7 Jan 2026.